You are here

Article info

Article menu

Download PDFPDF

Review
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem

Authors

  • Kikkie Poels Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Suzanne I.M. Neppelenbroek Department of Psychosocial Research and Epidemiology (PSOE), Netherlands Cancer Institute, Amsterdam, NetherlandsDepartment of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Marie José Kersten Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • M. Louisa Antoni Department of Cardiology, Heart Lung Centre, Leiden University Medical Centre, Leiden, Netherlands PubMed articlesGoogle scholar articles
  • Esther Lutgens Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, NetherlandsInstitute for Cardiovascular Prevention (IPEK), Ludwig Maximilian's University, Munich, GermanyGerman Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany PubMed articlesGoogle scholar articles
  • Tom T.P. Seijkens Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, NetherlandsDepartment of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, NetherlandsDepartment of Medical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Tom T.P. Seijkens; t.t.seijkens{at}amsterdamumc.nl
View Full Text

Citation

Poels K, Neppelenbroek SI, Kersten MJ, et al
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
Journal for ImmunoTherapy of Cancer 2021;9:e002916. doi: 10.1136/jitc-2021-002916

Publication history

  • Accepted June 8, 2021
  • First published June 24, 2021.
Online issue publication 
June 24, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.